Zq. Yao et al., Site-directed mutation in a conserved kinase domain of human cytomegalovirus-pp65 with preservation of cytotoxic T lymphocyte targeting, VACCINE, 19(13-14), 2001, pp. 1628-1635
The major target of human cytomegalovirus (CMV)-specific cytotoxic T lympho
cytes (CTL) is the tegument protein CMVpp65. However, this protein has prot
ein kinase (PK) activity, and the unknown effects on cell replication of an
exogenous PK in healthy cells could limit the use of CMVpp65 as a vaccine,
especially in children. In this report we show that a point mutation conve
rting lysine to asparagine at the invariant lysine (K436), an essential sit
e for phosphotransfer, abolishes the threonine kinase activity. The mutant
CMVpp65 maintains its immunologic target characteristics, including antibod
y and CTL reactivity. This kinase-deficient CMVpp65 is a candidate for eval
uation in future CMV vaccine development. (C) 2001 Published by Elsevier Sc
ience Ltd.